The numbers tell a stark story. Pharmaceutical companies have invested billions in omnichannel platforms, AI-driven personalization, and sophisticated customer engagement technologies. Yet when we talk with pharma executives, one of the first challenges they bring up is their inability to deliver the seamless HCP experiences they envisioned.
.png)
When business leaders look to improve performance, behavioral science isn’t usually their first stop—but it often should be.
Once you’ve reached the go-live stage of a big transition project, you’ll be greeted with both good news and bad news.
There’s been a lot of noise lately about the “death” of consulting, especially with the rise of artificial intelligence (AI). But as Luk Smeyers aptly put it, “Consulting is not dead. Stop the nonsense.” We couldn’t agree more.
Conversation